FDA Inspection 1225712 — Dr. James A. Thompson, M.D.

Dr. James A. Thompson, M.D. — FEI 3027372751

The FDA completed an inspection of Dr. James A. Thompson, M.D. on December 20, 2023 in Saint Petersburg, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 20, 2023
Fiscal Year
2024
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Saint Petersburg, FL (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
297421 CFR 812.110(b)Investigator non-compliance with agreement/plan/regulations
701321 CFR 812.110(d)Inadequate financial disclosure by investigator